Articles

Use of metformin may decrease chances of developing gastric cancer in patients with T2D.

Guest Post by David Kliff, Editor, Diabetic Investor

The so-called “high” cost of insulin continues to get lots of attention. But as I’ve noted before, little perspective has been given to this debate and far too many facts are missing. Yes, I know facts are pesky things, but they are facts nonetheless. Allow me for a moment to provide some examples.

Low carbs equals lower blood sugars and control, with less hypoglycemia, but how low do our patients need to go?

Pooled analysis from two randomized trials shows significant differences in effects on two groups.

Study looks at whether intensive BP lowering can increase the risk of CKD.

According to a recent published study, HbA1c variability is a better predictor of mortality in patients with type 2 diabetes compared with HbA1c averages.

High blood pressure and prediabetes together may do more harm to the body than either one alone.

Two of the four exciting treatment options currently being trialed could change the way the disease is treated long term.

New exciting treatment options currently being trialed could change the way the disease is treated long term.

Study answers questions of risk difference based on demographics.